Ballentine Partners’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
Ballentine Partners's ADNT Position: Q3 2026 in Review
Ballentine Partners increased its Adient (ADNT) stake by 18% in Q3 2026, buying an estimated $34.2K and bringing the position to 11,879 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.
Ballentine Partners first reported a position in ADNT in Q2 2025 and has held it in 6 quarters since. The position peaked at $278K in Q3 2025. 302 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.
- Ballentine Partners held 11,879 shares of Adient worth $200K as of Q3 2026.
- Ballentine Partners bought 1,773 Adient shares in Q3 2026, an estimated $34.2K.
- Adient made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #1058 holding.
- Ballentine Partners first reported a position in Adient in Q2 2025 and has held it in 6 quarters since.
- Ballentine Partners's Adient position peaked at $278K in Q3 2025.
- 302 funds tracked by Wall St. Rank held Adient as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.